539428 — Tejnaksh Healthcare Share Price
- IN₹448.74m
- IN₹430.84m
- IN₹121.75m
- 98
- 30
- 61
- 72
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.86 | ||
Price to Tang. Book | 2.3 | ||
Price to Free Cashflow | 61.73 | ||
Price to Sales | 3.67 | ||
EV to EBITDA | 10.39 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 10.89% | ||
Return on Equity | 9.57% | ||
Operating Margin | 26.28% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 167.57 | 119.6 | 126.76 | 117.27 | 121.75 | n/a | n/a | -9.23% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -30.92 | -1.78 | +34.29 | -38.97 | +5.03 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Tejnaksh Healthcare Limited is an India-based holding company, which is engaged in the healthcare services and pharmacies business. The Company is focused on the provision of hospital and healthcare services in Mumbai and other parts of Maharashtra. The Company operates through one segment: Medical and Healthcare Services. The Company's domains include Multi-specialty Hospital, Super Specialty Hospital, Pathology Lab, research and development, pharmaceutical, Healthcare Equipment, Super Specialty Training Institutes, Stone Analysis Lab Education Institutes, and Simulation Institute. Its Healthcare Equipment includes a stone manipulation simulator, an ultrasound guided perc simulator, and a radiation-free perc simulator. It provides healthcare services at approximately 13 urology clinics, four urology hospitals, and two dental superspecialist clinics.
Directors
- Ramesh Kuwar CFO
- Shaikh Afrinas CCO
- Ashish Rawandale MDR (43)
- Yaser Ahmedd OTH
- Gautam Ladumor OTH
- Lokesh Patni OTH
- Sanjay Khatal NED
- Preeti Rawandale NED (39)
- Vikramsingh Patil NID (33)
- Kiran Pawar NID (41)
- Suhas Thorat NID (54)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 18th, 2008
- Public Since
- October 27th, 2015
- No. of Employees
- 38
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Bombay Stock Exchange
- Shares in Issue
- 20,314,000

- Address
- Sakri Road, Dhule, MUMBAI, 424001
- Web
- https://tejnaksh.com/
- Phone
- +91 2562245995
- Auditors
- P.D. DALAL & CO.
Upcoming Events for 539428
Q1 2026 Tejnaksh Healthcare Ltd Earnings Release
Tejnaksh Healthcare Ltd Annual Shareholders Meeting
Similar to 539428
Aashka Hospitals
Bombay Stock Exchange
Abate As Industries
Bombay Stock Exchange
Asarfi Hospital
Bombay Stock Exchange
Aspira Pathlab & Diagnostics
Bombay Stock Exchange
Broach Lifecare Hospital
Bombay Stock Exchange
FAQ
As of Today at 23:36 UTC, shares in Tejnaksh Healthcare are trading at IN₹22.75. This share price information is delayed by 15 minutes.
Shares in Tejnaksh Healthcare last closed at IN₹22.75 and the price had moved by -7.86% over the past 365 days. In terms of relative price strength the Tejnaksh Healthcare share price has underperformed the S&P BSE 100 Index by -13.2% over the past year.
There is no consensus recommendation for this security.
Find out moreTejnaksh Healthcare does not currently pay a dividend.
Tejnaksh Healthcare does not currently pay a dividend.
Tejnaksh Healthcare does not currently pay a dividend.
To buy shares in Tejnaksh Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹22.75, shares in Tejnaksh Healthcare had a market capitalisation of IN₹448.74m.
Here are the trading details for Tejnaksh Healthcare:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 539428
Based on an overall assessment of its quality, value and momentum Tejnaksh Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tejnaksh Healthcare. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -4.71%.
As of the last closing price of IN₹22.75, shares in Tejnaksh Healthcare were trading -6.01% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tejnaksh Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹22.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tejnaksh Healthcare's management team is headed by:
- Ramesh Kuwar - CFO
- Shaikh Afrinas - CCO
- Ashish Rawandale - MDR
- Yaser Ahmedd - OTH
- Gautam Ladumor - OTH
- Lokesh Patni - OTH
- Sanjay Khatal - NED
- Preeti Rawandale - NED
- Vikramsingh Patil - NID
- Kiran Pawar - NID
- Suhas Thorat - NID